Orthogon Therapeutics logo

Orthogon Therapeutics Funding & Investors

Braintree, MA

Orthogon Therapeutics is a preclinical-stage drug design company that leverages a constellation of innovative technologies to discover and develop small molecules that modulate challenging but sought-after drug targets. It focuses on the development of antiviral drugs for immune-suppressed patients.

orthogontherapeutics.com

Total Amount Raised: $23,600,000

Orthogon Therapeutics Funding Rounds

  • Series Unknown

    $5,200,000

  • Series Unknown

    $6,000,000

  • Series B

    $8,000,000

  • Series A

    $4,400,000

    Series A Investors

    Over-the-Rhine Foundation
    Holbrook Angels of Boston
Funding info provided by Diffbot.